In its latest 13F filing, Lomas Capital Management, run by Daniel Lascano, unveiled its top 3 equity picks. The list is made up of Sealed Air Corp (NYSE:SEE), Louisiana-Pacific Corporation (NYSE:LPX) and Gilead Sciences, Inc. (NASDAQ:GILD). The fund also disclosed a reduction its equity portfolio value in the third quarter of 2014. It closed the quarter with nearly $516 million in equity while it had about $558 million in the same in the second quarter of 2014.
Lomas Capital Management’s investment approach involves taking long/short positions mostly in the U.S. equities.
Sealed Air Corp (NYSE:SEE) tops the list of Lomas Capital Management’s best three equity picks. The fund held 1.1 million shares in the food safety company at the end of the third quarter of 2014. The position in Sealed Air Corp (NYSE:SEE) remained unchanged from the previous filing but the value edged up to about $39 million.
Sealed Air Corp (NYSE:SEE) has witnessed a few insider activities this year. The company’s Director, P Kenneth Manning, acquired 10,000 shares in the company this week. However, Z. Emile Chammas, SVP, is the only insider seller in the company so far this year. Chammas sold 20,000 shares.
Lomas Capital Management had Louisiana-Pacific Corporation (NYSE:LPX) as its second-best equity pick in the third quarter of 2014. It boosted position in the maker of building products to nearly 1.97 million shares from slightly over 1.35 million shares in the previous report. The new position carried an estimated value of $27 million.
Louisiana-Pacific Corporation (NYSE:LPX) is also a significant position in the portfolio of Alden Global Capital, managed by Randall Smith. The firm increased its exposure to the stock by 102% in the second quarter of 2014. It closed the quarter with more than 2 million shares there.
The list of Lomas Capital Management’s top three best stocks is closed by Gilead Sciences, Inc. (NASDAQ:GILD). Lomas Capital Management reduced its exposure to the stock of Gilead Sciences, Inc. (NASDAQ:GILD) in the third quarter of 2014. As such, it owned 237,940 shares in the drug company in the latest filing. However, the previous filing revealed ownership of 246,490 shares in the company. The new position is valued at more than $25 million.
Tiger Management, by Julian Robertson, increased its exposure to the stock of Gilead Sciences, Inc. (NASDAQ:GILD) in the second quarter of 2014. The fund owned 443,911 shares in the company at the end of the quarter, making it one of its significant equity stakes.
Suggested Articles:
